States with greater increases in symptoms had fewer deaths from COVID-19 and lower women's unemployment rates
Common reasons for not seeking treatment include cost, not knowing where to go for services, fear of being committed or having to take meds
Treatments based on cognitive behavioral therapies may reduce depressive symptoms, but evidence lacking for effect on anxiety
Prevalence of smoking decreased for U.S. adults with major depressive episode, substance use disorder, or both between 2006 and 2019
No improvement seen in physical or mental health-related quality of life
Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for those aged 8 to 18 years
One-third of teens show early depression response with substance use treatment alone
Compared with nurse interview, self-administered screening may detect more patients at risk for depression, falls, intimate partner violence
Prevalence of symptoms of depression and anxiety increased among those with COVID-19 who were bedridden for more than seven days
From 2019 to 2020, increases seen in behavior or conduct problems and decreases seen in preventive medical visits